A hidden twist: Twiddler's syndrome presenting as inappropriate shock in a subcutaneous implantable cardioverter-defibrillator. [PDF]
Cantisán Campillos R +3 more
europepmc +1 more source
This study is a comprehensive post‐market analysis of the Xenios console and XLung kit 230 preconfigured ECMO tubing set in post‐cardiotomy applications. The performance of this device was evaluated and demonstrated in all key clinical areas, with an adequate safety profile.
Luca Conci +9 more
wiley +1 more source
A bibliometric and visual analysis of implantable cardioverter defibrillator use in hypertrophic cardiomyopathy: 2000-2025. [PDF]
Li Y, Chen Z, Cheng B, Li J, Ai F.
europepmc +1 more source
ABSTRACT Rationale Twenty‐first century healthcare has struggled with chronic illnesses while policies have emphasised patient centeredness and support. The importance of ambulatory visits and self‐management necessitate understanding about supportive outpatient‐provider communication.
Sari Knaapi‐Junnila +2 more
wiley +1 more source
Incidence and Determinants of Implantable Cardioverter-Defibrillator Therapy With Loss of and Impaired Consciousness. [PDF]
Noordman ABP +5 more
europepmc +1 more source
The Subcutaneous Implantable Cardioverter Defibrillator [PDF]
openaire +2 more sources
QT Interval Evaluation in Right Ventricular Pacing: Validation of a Novel Formula
ABSTRACT Background QT interval measurement in the presence of right ventricular pacing (RVP) represents a clinical challenge. We therefore aimed to derive and validate a formula for QT estimation during RVP in a large cohort of pacemaker patients. Methods and Results We prospectively enrolled 100 patients in a derivation cohort and 487 in a validation
Amr Abdin +9 more
wiley +1 more source
Surgical extravascular implantable cardioverter-defibrillator lead implant when transvenous therapy is undesirable. [PDF]
Bik A +5 more
europepmc +1 more source
ABSTRACT Background Implantable cardioverter‐defibrillator (ICD) therapy relies on reliable right ventricular leads for pacing, sensing, and defibrillation. The INVICTA DF4 lead is an active‐fixation, quadripolar design intended to optimize implant workflow and long‐term safety and performance. Methods APOLLO was a prospective, multicenter, single‐arm,
Klaus K. Witte +13 more
wiley +1 more source
Extravascular implantable cardioverter-defibrillator implantation strategies following transvenous or subcutaneous device infections: a case series. [PDF]
Ono S +7 more
europepmc +1 more source

